IN8bio Inc. (INAB)
NASDAQ: INAB
· Real-Time Price · USD
2.09
-0.02 (-1.04%)
At close: Oct 17, 2025, 3:59 PM
2.10
0.43%
After-hours: Oct 17, 2025, 07:31 PM EDT
IN8bio Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
Revenue | n/a | n/a | n/a | n/a |
Cost of Revenue | 2.65M | 2.5M | 1.1M | 251K |
Gross Profit | -2.65M | -2.5M | -1.1M | -251K |
Operating Income | -29.6M | -30.34M | -28.52M | -14.65M |
Interest Income | 230K | n/a | n/a | n/a |
Pretax Income | -30.44M | -30.01M | -28.52M | -14.65M |
Net Income | -30.44M | -30.01M | -28.52M | -14.65M |
Selling & General & Admin | 12.64M | 13.51M | 14.46M | 7.31M |
Research & Development | 16.96M | 16.83M | 14.06M | 7.35M |
Other Expenses | -2.65M | -2.5M | n/a | n/a |
Operating Expenses | 26.94M | 27.84M | 28.52M | 14.65M |
Interest Expense | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a |
Cost & Expenses | 29.6M | 30.34M | 28.52M | 14.65M |
Income Tax Expense | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 53.55M | 29.86M | 20.97M | 18.78M |
Shares Outstanding (Diluted) | 53.55M | 29.86M | 20.97M | 18.78M |
EPS (Basic) | -0.57 | -1 | -1.36 | -0.78 |
EPS (Diluted) | -0.57 | -1 | -1.36 | -0.78 |
EBITDA | -27.78M | -27.51M | -27.42M | -14.4M |
EBIT | -30.44M | -30.01M | -28.52M | -14.65M |
Depreciation & Amortization | 2.65M | 2.5M | 1.1M | 251K |
Source: Financial Modeling Prep. Financial Sources.